lofexidine Lucemyra
Selected indexed studies
- Lofexidine. (, 2006) [PMID:30000984]
- Lofexidine (Lucemyra) for opioid withdrawal. (Med Lett Drugs Ther, 2018) [PMID:30036346]
- Lofexidine (Lucemyra) for Treatment of Opioid Withdrawal Symptoms. (Am Fam Physician, 2019) [PMID:30874408]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- New directions in the treatment of opioid withdrawal. (2020) pubmed
- Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose: A Review. (2026) pubmed
- Lofexidine. (2006) pubmed
- Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: A systematic review. (2020) pubmed
- Lofexidine: A Newly FDA-Approved, Nonopioid Treatment for Opioid Withdrawal. (2019) pubmed
- Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. (2010) pubmed
- Lofexidine for opiate detoxification: review of recent randomised and open controlled trials. (1999) pubmed
- Lofexidine (Lucemyra) for opioid withdrawal. (2018) pubmed
- Lofexidine (Lucemyra) for Treatment of Opioid Withdrawal Symptoms. (2019) pubmed
- Pharmaceutical Approval Update. (2018) pubmed